Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Blood Advances|May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myelomaMateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
Haematologica|November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.
Blood|May 5, 2018
High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AMLSanjay S Patel, Frank C Kuo, Christopher J Gibson, et al.
Blood Advances|January 4, 2018
Constitutive Ras signaling and <i>Ink4a/Arf</i> inactivation cooperate during the development of B-ALL in miceTomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, et al.
Transplantation and Cellular Therapy|August 9, 2022
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell LymphomaKarthik Nath, Ana Alarcon Tomas, Jessica Flynn, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Leukemia|July 1, 2026
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasmsRyan Nachman, Aleksandra Kopacz, Caitlin Unkenholz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of <i>TP53</i> Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
The Lancet. Haematology|February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Frontiers in Immunology|April 17, 2024
Donor <i>KIR</i> genotype based outcome prediction after allogeneic stem cell transplantation: no land in sightJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Pageof 7